Cerebras Systems Inc.
196.20USD
-3.5700 (-1.79%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.14▼ | $0 | 9 | 0 |
| Next quarter | $-0.22▼ | $0 | 9 | 0 |
| Current year | $-0.47▼ | $0 | 9 | 0 |
| Next year | $1.27▲ | $0 | 9 | 0 |
Beat in 2 of the last 2
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $-0.18 | $-0.05 | +0.13 (+74.6%) |
| 2026-03-31 | $-0.15 | $-0.04 | +0.11 (+74.0%) |
26 ratings from 11 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Rosenblatt | Maintained | Buy | $300 | Aug 19, 2026 |
| Needham | Reiterated | Buy | $300 | Aug 19, 2026 |
| UBS | Maintained | Buy | $320 $330 | Aug 13, 2026 |
| Citigroup | Maintained | Buy | $340 $320 | Aug 13, 2026 |
| Wedbush | Maintained | Outperform | $280 $290 | Aug 13, 2026 |
| Mizuho | Maintained | Outperform | $310 $300 | Aug 13, 2026 |
| Rosenblatt | Maintained | Buy | $300 | Aug 13, 2026 |
| Morgan Stanley | Maintained | Overweight | $273 $279 | Aug 13, 2026 |
| Needham | Reiterated | Buy | $300 | Aug 13, 2026 |
| Mizuho | Maintained | Outperform | $300 $310 | Jul 27, 2026 |
| Freedom Capital Markets | Initiated | Hold | $209 | Jun 30, 2026 |
| UBS | Maintained | Buy | $300 $320 | Jun 24, 2026 |
| Rosenblatt | Maintained | Buy | $300 | Jun 24, 2026 |
| Wedbush | Maintained | Outperform | $270 $280 | Jun 24, 2026 |
| Morgan Stanley | Maintained | Overweight | $250 $273 | Jun 24, 2026 |
| Needham | Reiterated | Buy | $300 | Jun 24, 2026 |
| Craig-Hallum | Initiated | Buy | $325 | Jun 9, 2026 |
| Mizuho | Initiated | Outperform | $300 | Jun 8, 2026 |
| Morgan Stanley | Initiated | Overweight | $250 | Jun 8, 2026 |
| TD Cowen | Initiated | Buy | $275 | Jun 8, 2026 |
| UBS | Initiated | Buy | $300 | Jun 8, 2026 |
| Citigroup | Initiated | Buy | $340 | Jun 8, 2026 |
| Barclays | Initiated | Overweight | $280 | Jun 8, 2026 |
| Wedbush | Initiated | Outperform | $270 | Jun 8, 2026 |
| Rosenblatt | Initiated | Buy | $300 | Jun 8, 2026 |
77 filings from 15 insiders · 29 buy / 15 sell over 6m
Officers and directors of CBRS, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Feldman Andrew D.Director; Officer, CEO, President | Otherindirect | 120 | — | — | Sep 8, 2026 |
| Vassallo StevenDirector | Sellindirect | 7.1k | $211.56 | $1.50M | Sep 4, 2026 |
| Vassallo StevenDirector | Sellindirect | 21.8k | $210.37 | $4.58M | Sep 4, 2026 |
| Vassallo StevenDirector | Sellindirect | 21.1k | $209.81 | $4.43M | Sep 4, 2026 |
| Lie SeanOfficer, Chief Technology Officer | ExerciseClass B Common Stock | 46.1k | — | — | Sep 4, 2026 |
| Lie SeanOfficer, Chief Technology Officer | ExerciseClass B Common Stock | 46.1k | — | — | Sep 4, 2026 |
| Lie SeanOfficer, Chief Technology Officer | ExerciseStock Option | 46.1k | — | — | Sep 4, 2026 |
| Lie SeanOfficer, Chief Technology Officer | Sell | 53.5k | $210.16 | $11.24M | Sep 4, 2026 |
| Lie SeanOfficer, Chief Technology Officer | Gift | 16.0k | — | — | Sep 4, 2026 |
| Lie SeanOfficer, Chief Technology Officer | Exercise | 46.1k | — | — | Sep 4, 2026 |
| Feldman Andrew D.Director; Officer, CEO, President | ExerciseClass B Common Stock | 37.4k | — | — | Sep 4, 2026 |
| Feldman Andrew D.Director; Officer, CEO, President | ExerciseClass B Common Stock | 37.4k | — | — | Sep 4, 2026 |
| Feldman Andrew D.Director; Officer, CEO, President | ExerciseStock Option | 37.4k | — | — | Sep 4, 2026 |
| Feldman Andrew D.Director; Officer, CEO, President | Sell | 100 | $216.62 | $22k | Sep 4, 2026 |
| Feldman Andrew D.Director; Officer, CEO, President | Sell | 600 | $215.81 | $129k | Sep 4, 2026 |
| Feldman Andrew D.Director; Officer, CEO, President | Sell | 1.4k | $214.98 | $301k | Sep 4, 2026 |
| Feldman Andrew D.Director; Officer, CEO, President | Sell | 3.9k | $213.95 | $834k | Sep 4, 2026 |
| Feldman Andrew D.Director; Officer, CEO, President | Sell | 3.3k | $213.04 | $708k | Sep 4, 2026 |
| Feldman Andrew D.Director; Officer, CEO, President | Sell | 7.4k | $211.85 | $1.58M | Sep 4, 2026 |
| Feldman Andrew D.Director; Officer, CEO, President | Sell | 6.2k | $210.91 | $1.30M | Sep 4, 2026 |
No analyst notes on CBRS yet.
Analyst Ratings
11 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 7 | 1 | 0 | 0 | Buy1.82 |
| 1 mo ago | 3 | 7 | 1 | 0 | 0 | Buy1.82 |
| 2 mo ago | 3 | 7 | 1 | 0 | 0 | Buy1.82 |